These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305 [TBL] [Abstract][Full Text] [Related]
8. Acute Hypotension after High-Intensity Interval Exercise in Metabolic Syndrome Patients. Morales-Palomo F; Ramirez-Jimenez M; Ortega JF; Pallarés JG; Mora-Rodriguez R Int J Sports Med; 2017 Jul; 38(7):560-567. PubMed ID: 28482361 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme 2 polymorphisms and postexercise hypotension in hypertensive medicated individuals. Goessler KF; Polito MD; Mota GF; de Oliveira EM; Cornelissen VA Clin Physiol Funct Imaging; 2018 Mar; 38(2):206-212. PubMed ID: 27925380 [TBL] [Abstract][Full Text] [Related]
10. Effects of ACEi and ARB on post-exercise hypotension induced by exercises conducted at different times of day in hypertensive men. Brito LC; Azevêdo L; Peçanha T; Fecchio RY; Rezende RA; da Silva GV; Pio-Abreu A; Mion D; Halliwill JR; Forjaz CLM Clin Exp Hypertens; 2020 Nov; 42(8):722-727. PubMed ID: 32589058 [TBL] [Abstract][Full Text] [Related]
11. Effect of 12 weeks of resistance exercise on post-exercise hypotension in stage 1 hypertensive individuals. Moraes MR; Bacurau RF; Simões HG; Campbell CS; Pudo MA; Wasinski F; Pesquero JB; Würtele M; Araujo RC J Hum Hypertens; 2012 Sep; 26(9):533-9. PubMed ID: 21734721 [TBL] [Abstract][Full Text] [Related]
13. High-intensity interval exercise promotes post-exercise hypotension of greater magnitude compared to moderate-intensity continuous exercise. Pimenta FC; Montrezol FT; Dourado VZ; da Silva LFM; Borba GA; de Oliveira Vieira W; Medeiros A Eur J Appl Physiol; 2019 May; 119(5):1235-1243. PubMed ID: 30848358 [TBL] [Abstract][Full Text] [Related]
14. Endurance Exercise Training reduces Blood Pressure according to the Wilder's Principle. Mora-Rodriguez R; Ortega JF; Morales-Palomo F; Ramirez-Jimenez M; Moreno-Cabañas A; Alvarez-Jimenez L Int J Sports Med; 2022 Apr; 43(4):336-343. PubMed ID: 34560789 [TBL] [Abstract][Full Text] [Related]
15. Dietary Caffeine and Polyphenol Supplementation Enhances Overall Metabolic Rate and Lipid Oxidation at Rest and After a Bout of Sprint Interval Exercise. Jo E; Lewis KL; Higuera D; Hernandez J; Osmond AD; Directo DJ; Wong M J Strength Cond Res; 2016 Jul; 30(7):1871-9. PubMed ID: 27331913 [TBL] [Abstract][Full Text] [Related]
16. The training and detraining effect of high-intensity interval training on post-exercise hypotension in young overweight/obese women. Bonsu B; Terblanche E Eur J Appl Physiol; 2016 Jan; 116(1):77-84. PubMed ID: 26293124 [TBL] [Abstract][Full Text] [Related]
17. Post-exercise hypotension time-course is influenced by exercise intensity: a randomised trial comparing moderate-intensity, high-intensity, and sprint exercise. Jones MD; Munir M; Wilkonski A; Ng K; Beynon G; Keech A J Hum Hypertens; 2021 Sep; 35(9):776-784. PubMed ID: 32980866 [TBL] [Abstract][Full Text] [Related]
18. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database. Mancia G; Omboni S; Chazova I; Coca A; Girerd X; Haller H; Parati G; Pauletto P; Pupek-Musialik D; Svyshchenko Y; J Hypertens; 2016 Jan; 34(1):139-48. PubMed ID: 26630216 [TBL] [Abstract][Full Text] [Related]
19. An ambulatory blood pressure monitoring study of the comparative antihypertensive efficacy of two angiotensin II receptor antagonists, irbesartan and valsartan. Mancia G; Korlipara K; van Rossum P; Villa G; Silvert B Blood Press Monit; 2002 Apr; 7(2):135-42. PubMed ID: 12048432 [TBL] [Abstract][Full Text] [Related]
20. Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension. Wong GW; Boyda HN; Wright JM Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD007450. PubMed ID: 25427719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]